Since its inception in 1994, Express Diagnostics Ltd has been dedicated to providing convenient access to high-quality cardiac investigation services for GPs and local hospitals. However, over the past 29 years, the company has expanded significantly, evolving into a leading provider of cardiology services for the clinical trials industry. Additionally, it has established a state-of-the-art private health clinic to cater to the general public. With an unwavering commitment to patient care, Express Diagnostics Ltd offers specialised cardiac investigations, conducts data analysis for clinical research, and delivers a wide range of diagnostic services to contribute to the early detection and management of cardiovascular diseases in both clinical and public settings.
We are pleased to formally announce a significant development at Express Diagnostics. We are proud to inform our valued stakeholders that Inuvi, a distinguished leader in the realm of health data and insight, renowned for its state-of-the-art laboratory services and unwavering commitment to innovation, has successfully acquired Express Diagnostics. As Express Diagnostics, a leading provider of diagnostic services to esteemed institutions such as the NHS, the independent healthcare sector, and the clinical trials industry, joins hands with Inuvi, we anticipate a profound transformation in our capabilities and offerings. This strategic alliance underscores our steadfast dedication to upholding the highest standards of excellence in diagnostics and healthcare services. Together, with Inuvi, we are poised to play an even more pivotal role in ensuring greater certainty in the domains of insurance, health, and social research. We express our gratitude to all our stakeholders and look forward to sharing exciting developments on this journey.
We provide the devices, consumables, encrypted data transfer software, staff training in how to use the device(s), analysis service with trigger list identification and/or cardiologist over-read options.